Fundraising FoxvenBio Partners — 2026 Investments
3 investments dated 2026 · listed companies and verified rows first · show all
Entact is a drug discovery company developing treatments for patients.
BiotechDeep TechWatertown, US
Victoria Richon(Executive Officer, Director, Promoter)inRuben Tommasi(Chief Scientific Officer)Michael Gutch(Chief Operating Officer)Alon Lazarus(Director)
BoardAndrew Sinclair(Director)Anna French(Director)in
Co-investorsAbingworthArkin CapitalQiming Venture PartnersvenBio Global Strategic
Oak Hill Bio develops therapies for patients with rare diseases, supported by experienced life science investors.
BiotechHealthtechMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.